About SEC14-like protein 6
SEC14-like protein 6 (SEC14L6) is a protein
from Homo sapiens identified by UniProt accession
B5MCN3, 397 residues long.
MolForge cross-references it against 0 known binders and
18 disease associations.
Target properties
| Protein name | SEC14-like protein 6 |
| UniProt accession | B5MCN3 |
| Gene | SEC14L6 |
| Organism | Homo sapiens |
| Length | 397 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (18)
Diseases linked to this target (Open Targets).
- white matter microstructure measurement · score 0.13
- neuroimaging measurement · score 0.11
- apolipoprotein A 1 measurement · score 0.10
- brain measurement · score 0.09
- brain volume measurement · score 0.09
- glycerophospholipid measurement · score 0.06
- high density lipoprotein cholesterol measurement · score 0.06
- sporadic Creutzfeld Jacob disease · score 0.05
- body height · score 0.04
- HbA1c measurement · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-B5MCN3-F1 | alphafold | PREDICTED | 94.19 | — |
Amino-acid sequence (397 residues)
MSGQVGDLSP SQEKSLAQFR ENIQDVLSAL PNPDDYFLLR WLQARSFDLQ KSEDMLRKHM EFRKQQDLAN ILAWQPPEVV RLYNANGICG HDGEGSPVWY HIVGSLDPKG LLLSASKQEL LRDSFRSCEL LLRECELQSQ KLGKRVEKII AIFGLEGLGL RDLWKPGIEL LQEFFSALEA NYPEILKSLI VVRAPKLFAV AFNLVKSYMS EETRRKVVIL GDNWKQELTK FISPDQLPVE FGGTMTDPDG NPKCLTKINY GGEVPKSYYL CKQVRLQYEH TRSVGRGSSL QVENEILFPG CVLRWQFASD GGDIGFGVFL KTKMGERQRA REMTEVLPSQ RYNAHMVPED GILTCLQAGS YVLRFYNTYS LVHSKRISYT VEVLLPDQTF MEKMEKF
Explore SEC14-like protein 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets